Agnieszka Pluta

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 231 citations · Full text

Regenerative Medicine, Cell Therapy, Transplantation +7

Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G‐CSF (CLAG‐M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group

Agnieszka Wierzbowska, Tadeusz Robak, Agnieszka Pluta et al. · European Journal Of Haematology · 2007 · 142 citations · Full text

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Sebastian Grosicki, Tadeusz Robak, Sławomira Kyrcz‐Krzemień et al. · Leukemia · 2004 · 125 citations · Full text

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +8

Circulating endothelial cells in patients with acute myeloid leukemia

Agnieszka Wierzbowska, Tadeusz Robak, Anna Krawczyńska et al. · European Journal Of Haematology · 2005 · 64 citations

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

Agata Wrzesień‐Kuś, Tadeusz Robak, Agnieszka Wierzbowska et al. · Annals of Hematology · 2005 · 42 citations

Hematological Malignancy, Induction Therapy, Medicine +11